Sponsors & Exhibitors
Diamond sponsor
Soterix Medical
Soterix Medical, the global leader in Noninvasive Neuromodulation, introduced High Definition-transcranial Electrical Stimulation (HD-tES) and remote-supervised tES (RS-tES). HD-tES is the only targeted sub-threshold Neuromodulation technology and allows coupling with research-grade monitoring technologies like EEG, MEG, fNIRS, etc. Coupled with Advanced Neurotargeting software, which allows the design of optimized and individualized stimulation along with the current flow visualization, HD-tES allows customized stimulation for susceptible populations (stroke, pediatric, etc).
RS-tES enables remote delivery of tES maintaining in-clinic compliance and control. Soterix Medical also offers a range of innovative technologies from conventional tDCS, Interferential Stimulation, Transcranial Magnetic Stimulation(TMS), Transcranial Pulse Stimulation, Neuronavigation, HD-ECT, Spinal Cord, Galvanic Vestibular, Vagus Nerve to Animal Stimulation and monitoring solutions (EEG,fNIRS, EMG).
Platinum sponsor
Brainbox
Enabling the very best neuroscience research with tailored and integrated non-invasive brain stimulation and brain imaging solutions that include techniques such as TMS, tES, TUS, MEG, Neuronavigation, EMG, EEG, fNIRS and more.
Brainbox brings together decades of technical and academic expertise to provide a wide range of customisable solutions, together with expert hands-on training to satisfy even the most demanding of non-invasive brain stimulation research studies.
Gold sponsors
LivaNova
LivaNova is focused on improving the quality of patients’ lives with breakthrough treatments for conditions affecting the head and heart. LivaNova is a world leader in advanced circulatory support, cardiopulmonary, and neuromodulation with a presence in more than 100 countries worldwide. LivaNova’s differentiated pipeline targets several medical conditions with high unmet needs, including difficult-to-treat depression. With over 25 years of patient experience with Vagus Nerve Stimulation (VNS) Therapy® technology and over 100,000 patients implanted across multiple diseases, LivaNova is working to improve the lives of patients around the globe.
Magstim EGI
Magstim EGI is your neurotechnology research partner for EGI Electroencephalography (EEG), Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS) and other solutions to study and treat the brain. With 60+ years of neuroscience innovations backed by 20,000+ peer-reviewed publications, the Magstim EGI team will bring conference attendees innovations in HD-EEG and TMS as a treatment for nervous system and psychiatric disorders. This non-invasive neuromodulation allows researchers to unravel network connectivity of the brain to develop techniques and protocols to identify biomarkers, targeting for treatments and discovery.
Rogue Research
Rogue Research has been your partner in neuroscience research for 25 years with Brainsight used in over 1000 labs worldwide and now we offer our integrated Elevate TMS and companion Robot . Elevate Biomedical was recently created to facilitate translation from research to clinical trials to full clinical deployment.
Zabara Foundation
Visit website: https://zabarafoundation.org/ 新しいタブ／ウィンドウで開く
Silver sponsors
NeuroDome Ltd. (China) is a pioneer of engineering development and clinical translation in temporal interference (TI) brain stimulation. It is committed to providing lifelong treatment solutions for patients with central-peripheral nervous system diseases and chronic mental disorders. NeuroDome TI stimulators can achieve non-invasive, deep brain, high-precision, and multi-target brain stimulation. NeuroDome provides the services of TI stimulation, including technical support for clinical and basic TI studies, electric stimulators, FEM simulation software, stimulating/recording electrode interface, and concurrent electrophysiological recording during TI stimulation.
MagVenture
MagVenture is a market-leading manufacturer of non-invasive Transcranial Magnetic Stimulation (TMS) and Magnetic Peripheral Nerve Stimulation (mPNS) systems. Privately-owned and headquartered in Denmark, MagVenture has been pioneering cutting-edge magnetic stimulation solutions for more than 30 years.
MagVenture’s systems are used for a wide range of applications in both research and treatment in the fields of psychiatry, neurophysiology, neurology, cognitive neuroscience, and rehabilitation.
MagVenture’s products are available on the global market through subsidiaries in the USA, Germany, UK, China, and Brazil, and through a global network of distributors.
SigmaStim
SigmaStim is the world leader in the design, manufacture, and distribution of electroconvulsive therapy (ECT) devices and accessories. The Σigma is the newest ECT device produced by SigmaStim (formerly the MECTA Corporation). This Σigma has the widest range of stimulus parameters and physiological monitoring options of any ECT device. The Σigma is unparalleled in its ease of use, with an intuitive LCD interface allowing instant customization, including selection of single-dial or four-dial modes of operation.
Staring in 1976, with the original MECTA device, SigmaStim introduced the use of constant current, brief pulse ECT, a huge advance over previous constant voltage, sine wave devices. SigmaStim later introduced ultrabrief pulse stimulation and now the Σigma includes an option for ultra-ultrabrief stimulation with pulse widths ranging from 0.15-1.0 ms . SigmaStim introduced multiple other innovations including the continuous assessment of static impedance, true measurement of the delivered electrical stimulus including dynamic impedance, and with the Σigma ECT Device, the measurement of the impedance of each individual physiological recording electrode. The Σigma ECT Device can be coupled with SigmaStim EMR software providing automatic databasing of treatment session parameters, including physiological traces.
SigmaStim is sponsoring a one-day course at this meeting on Feb. 23, 2025, Introduction to Modern ECT Practice. The faculty in this course are Drs. Colleen Loo, W. Vaughn McCall, and Harold A. Sackeim.
STORZ MEDICAL AG
STORZ MEDICAL AG, founded in 1987, is an independent partner company of the KARL STORZ Group, based in Switzerland.
We develop innovative shock wave systems and discovered the effectiveness of shock waves in treating peripheral neurological diseases in the 1990s. Our focus now includes developing treatments for neurological diseases such as Alzheimer’s, Parkinson’s, stroke and spinal cord injuries.
Sponsors
Brainsonix
The BrainSonix Corporation develops transcranial Focused Ultrasound (tFUS) devices for non-invasive modulation of brain function. This technology can be used to target specific neuronal circuits using online or offline MRI-guided feedback, enabling precise stimulation or inhibition of deep brain regions without harmful effects. tFUS provides a novel approach for treating neurological and psychiatric disorders, including epilepsy, Parkinson’s, Alzheimer’s, anxiety, and chronic pain, by repairing malfunctioning circuits through targeted ultrasound pulses, offering a versatile tool for both clinical and research applications.
Vielight Inc
Vielight Inc. leads in the application of photobiomodulation (PBM) to modulate mental performance. Our proprietary technology, meticulously crafted for convenient home usage, redefines the landscape of brain stimulation.
Our exploration extends to diverse areas like dementia, traumatic brain injury and sports performance, revealing exciting potential. In addition, recent investigations demonstrate that the effect on brain functions are also acute and immediate, as observed with EEG and cognitive performance measures. The ease of use combined with safety suggests that PBM delivered by Vielight is very promising as the next-generation non-invasive brain stimulation method, ideal for lay users, hackers and researchers.
ZMT
ZMT Zurich MedTech AG (ZMT)’s flagship product Sim4Life combines in silico multiphysics and multi-scale computational modelling and simulation with advanced neurofunctionalized high-resolution anatomical models. The aim is to predict and optimize the effectiveness and performance of devices and stimulation parameters.
Together with its strategic partner TI Solutions AG, ZMT will showcase the newly developed Temporal Interference Brain Stimulator for Research (TIBS-R V2.0), the most flexible instrument to advance research on temporal interference stimulation. It’s multi-channel phase modulation capability enables the generation of complex interference waveforms. TIBS-R V2.0 is complemented by a cloud-based planning tool facilitating experimental design and optimization.
Recently, the ZMT team has achieved the impossible, namely releasing the full functionality of the Sim4Life desktop version natively on the web, which allows to access, share and collaborate in real-time.
TIBS-R is complemented by a cloud-based planning tool called TIP, that enables reliable simulations of complex and patient specific set-ups.
Exhibitors
ANT Neuro
ANT Neuro is a Dutch corporation specializing in the development, marketing, and sales of medical and research applications. ANT Neuro was established in 1997, as a spin-off company of the University of Twente, Enschede. It now has offices located in Hengelo, The Netherlands; Berlin, Germany; London, UK; Philadelphia, USA; Hong Kong, China; and Melbourne, Australia. ANT Neuro specializes in being a single-source provider of high performance products within neuroscience research and neurodiagnostics. Applications include EEG, EMG, TMS, and MEG technology. Using ANT Neuro products, functional brain information is fused with anatomical scans to gain insight into the working mechanisms of cognition and a variety of brain disorders. Our technology offers a wide range of applications in cognitive neuroscience, neurology, and psychiatry.
We are committed to serving our customers the best possible solutions available through our dedication to advancing the capabilities of neurotechnology, through steadfast relationships with our user community, and through helping further the collective understanding of the human brain, with the ultimate hope of improving human life. Leading in know-how and technology, we offer solutions and high-quality, state-of-the-art products and reliable services for expert customers worldwide. We team up with them to explore new ways, new dimensions and to tackle challenges. We think out of the box and act always one step ahead. We are ANT Neuro: We inspire!
Axilum Robotics
Axilum Robotics' objective is to provide researchers and health care professionals with robotic solutions to improve both technical medical procedures and medical resources management.
In 2013, the company launched TMS-Robot, the first medical robot specifically designed for Transcranial Magnetic Stimulation
In 2019, Axilum Robotics became the first robotic company worldwide to receive both CE mark and FDA 510(k) clearance for a medical device using a collaborative robotic arm : TMS-Cobot In 2024, the Company has customers in 20 countries and is developping the compatibility of its Cobot platform with transcranial ultrasound
Axilum Robotics is ISO 13485 certified for its Quality Management System since 2013.
Bittium
Bittium is a trusted Nordic company with over 30 years of experience in advanced biosignal processing. Bittium BrainStatus™ is a compact wireless EEG monitoring solution for continuous monitoring in ICU and ER. The easy and accurate installation of the electrodes enables EEG readings in a few minutes, making Bittium BrainStatus a fast and efficient solution for hospitals and field conditions.
Brainbox
Enabling the very best neuroscience research with tailored and integrated non-invasive brain stimulation and brain imaging solutions that include techniques such as TMS, tES, TUS, MEG, Neuronavigation, EMG, EEG, fNIRS and more.
Brainbox brings together decades of technical and academic expertise to provide a wide range of customisable solutions, together with expert hands-on training to satisfy even the most demanding of non-invasive brain stimulation research studies.
Brain Products
Visit website: www.brainproducts.com 新しいタブ／ウィンドウで開く
BrainsWay
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with offices in Burlington, MA and Jerusalem, Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com 新しいタブ／ウィンドウで開く.
Cambridge Electronic Design
We design and build data acquisition, analysis and experimental control systems for Windows using the powerful 1401 family of laboratory interfaces.
Using our Signal software it is possible to control intensities and stimulus timings of up to ten of the more popular magnetic stimulators simultaneously. Randomised timings and order of stimulus presentation is built-in, as are measurements of peak-to-peak amplitudes, latencies, and silent periods etc. Further control of the experiment protocol and customised analysis is available with the use of a script. Triggering based on force waveform profile is also available. www.ced.co.uk 新しいタブ／ウィンドウで開く
Century Medical, Inc.
Century Medical, Inc., headquartered in Tokyo, Japan, is an importer and distributor of advanced medical devices, dedicated exclusively to the Japanese market. Established in April 1974, we specialize in bringing innovative medical technologies to healthcare professionals, meeting the evolving needs of physicians. Century Medical continues to drive advancements in medical care through strategic partnerships and a commitment to improving patient outcomes.
For more information, please visit our website at https://www.cmi.co.jp/ 新しいタブ／ウィンドウで開く.
Cybermedic
http://www.cybermedic.co.kr 新しいタブ／ウィンドウで開く
The "NT Brain 48CH" model is a piece of equipment that measures the whole brain blood flow while the whole brain is stimulated through the 48 integrated probes of “HD-tDCS and fNIRS”.
DEYMED
DEYMED was founded in 1997 and its first product was developing a 32 channel EEG device which was completed and sold in 1998. In the following years additional products for neurology and psychiatry have been developed including EMG, PSG and TMS devices. The initial sales were to the Czech Republic but soon thereafter were offered in international markets. Due to the high level of innovation and modern design of the products, Deymed has become an established worldwide leader in neurology and psychiatry for both clinical and research applications.
EPI
EPI is a medical device company that designs, manufactures, and distributes cranial electrotherapy stimulation (CES) and microcurrent electrical therapy (MET) medical devices. In early 2022, EPI acquired Pulvinar Neuro LLC to accelerate the development and commercialization of its portfolio of products, including transcranial alternating current stimulation (tACS), individualized feedback stimulation, and cloud-enabled digital therapeutics.
EPI is committed to supporting the research community in advancing the future of noninvasive brain stimulation research.
Fraunhofer IBMT
Starting with theoretical studies using application-specific simulations, development of transducers and modular ultrasound systems including innovative software solutions, right up to signal processing, the department Ultrasound of the Fraunhofer IBMT covers the whole range of competences for system solutions in medical, biotechnological and technical applications.
With more than 40 members of staff in three business areas, and five highly specialized working groups, it is the largest ultrasound research unit in Europe. The competences of the working groups are based on more than 25 years of experience, and allow the development of all ultrasound system components, from materials with specially adapted properties, to application-specific ultrasound transducers, electronic system components and procedures, as well as software development, right up to sensor manufacturing and process development. Services range from consulting and feasibility studies to laboratory prototypes and prototype development, right up to certified product development, certification for clinical applications as well as clinical evaluation. An industrial share in turnover of around 70 % shows the high relevance of the department for a wide range of partners in industry.
g.tec
g.tec medical engineering GmbH has focused on developing and producing top-notch brain-computer-interface systems for 25 years. From non-invasive EEG to invasive ECoG research and clinical systems, from 8 to 1024 channels, from functional brain mapping to neurorehabilitation & neuromodulation etc., g.tec has been collaborating with top universities and hospitals to advance the BCI field.
LivaNova
LivaNova is focused on improving the quality of patients’ lives with breakthrough treatments for conditions affecting the head and heart. LivaNova is a world leader in advanced circulatory support, cardiopulmonary, and neuromodulation with a presence in more than 100 countries worldwide. LivaNova’s differentiated pipeline targets several medical conditions with high unmet needs, including difficult-to-treat depression. With over 25 years of patient experience with Vagus Nerve Stimulation (VNS) Therapy® technology and over 100,000 patients implanted across multiple diseases, LivaNova is working to improve the lives of patients around the globe.
Localite
Localite GmbH is an innovation company in the field of medical planning and positioning systems. It was founded in 2001, emerging from a project at the Fraunhofer Institute for Applied Information Technology.
Throughout the years Localite has been at the forefront of developing solutions for planning and navigation with the unwavering dedication to research and technological advancements that has played a role in shaping the future of neuromedicine.
Localite’s flagship product "TMS Navigator" entails a positioning system specifically designed for precise stimulation of the brain using transcranial magnetic stimulation (TMS). With Localite’s intuitive system, users can effectively plan, execute and document brain stimulations with the highest accuracy. In 2023, the company received FDA clearance for TMS Navigator TS, thereby contributing to making innovative treatment methods available for patient care.
Magstim EGI
Magstim EGI is your neurotechnology research partner for EGI Electroencephalography (EEG), Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS) and other solutions to study and treat the brain. With 60+ years of neuroscience innovations backed by 20,000+ peer-reviewed publications, the Magstim EGI team will bring conference attendees innovations in HD-EEG and TMS as a treatment for nervous system and psychiatric disorders. This non-invasive neuromodulation allows researchers to unravel network connectivity of the brain to develop techniques and protocols to identify biomarkers, targeting for treatments and discovery.
MagVenture
MagVenture is a market-leading manufacturer of non-invasive Transcranial Magnetic Stimulation (TMS) and Magnetic Peripheral Nerve Stimulation (mPNS) systems. Privately-owned and headquartered in Denmark, MagVenture has been pioneering cutting-edge magnetic stimulation solutions for more than 30 years.
MagVenture’s systems are used for a wide range of applications in both research and treatment in the fields of psychiatry, neurophysiology, neurology, cognitive neuroscience, and rehabilitation.
MagVenture’s products are available on the global market through subsidiaries in the USA, Germany, UK, China, and Brazil, and through a global network of distributors.
Miyuki
Miyuki Giken has been providing innovative solutions (products, technologies, information, and human network) evolved on the most advanced field of brain science in the world to researchers in Japan for 40 years and will keep supporting cutting-edge researches of neuroscience, physiology and psychology all the time from data acquisition to neuro modulation with our best partners.
Neurocare group AG
Neurocare is innovating mental health by delivering personalized therapy based on comprehensive assessments, utilizing cutting-edge engineering, science, and AI at our global network of clinics. We equip clinical and research professionals with the tools to address the underlying causes of mental and neurological disorders, empowering them to leverage the brain’s neuroplasticity for lasting positive change.
In addition to our Digital Therapy Platform (DTP) for integrated training and software solutions, we are a leading technology manufacturer with deep industry expertise. Our German-made TMS, tES, and DC-EEG technologies, under the brands neuroConn and MAG & More, provide sophisticated solutions like Closed-Loop systems, Neuronavigation, NIBS-EEG, Temporal Interference stimulation, and Target Engagement, supporting complex research initiatives.
At the International Brain Stimulation Conference 2025, we proudly present our MAG & More PowerMAG TMS stimulators and PowerMAG View! neuronavigation system, our neuroConn DC-STIMULATOR series for tDCS, tACS, and tRNS, along with our full-band DC-EEG products and LOOP-IT for closed-loop solutions. Our products seamlessly blend precision, usability, and can be fully customized for a variety of clinical applications or research experiments.
NeuroDome Ltd. (China) is a pioneer of engineering development and clinical translation in temporal interference (TI) brain stimulation. It is committed to providing lifelong treatment solutions for patients with central-peripheral nervous system diseases and chronic mental disorders. NeuroDome TI stimulators can achieve non-invasive, deep brain, high-precision, and multi-target brain stimulation. NeuroDome provides the services of TI stimulation, including technical support for clinical and basic TI studies, electric stimulators, FEM simulation software, stimulating/recording electrode interface, and concurrent electrophysiological recording during TI stimulation.
Neurosoft Europe
Neurosoft Europe is a world-known manufacturer of medical equipment with more than 30 years of experience. We are committed to improving the lives of patients worldwide through our innovative and cutting-edge solutions. Our presence spans over 100 countries, ensuring global accessibility to our pioneering technologies.
Our product portfolio includes products for noninvasive neuromodulation. Neurosoft Europe offers solutions for transcranial and peripheral magnetic stimulation and tDCS used for a wide range of applications in diagnostics, treatment and research in the fields of neurophysiology, neurology, psychiatry and rehabilitation. Our commitment to innovation is demonstrated by our extensive research and development efforts and collaborations with leading institutions and experts in the field.
Neurosoft Europe continuously improves and refines its technologies to meet the highest standards of safety, efficiency and quality.
NeuroStar
NeuroStar® Advanced Therapy is an FDA-cleared, non-drug, non-invasive Transcranial Magnetic Stimulation (TMS) treatment for adults and adolescents suffering from depression who are not satisfied with the results of antidepressant medications. Proven safe, proven effective, and proven to transform lives, NeuroStar is backed by the most robust service, support, and marketing in the industry. In addition to MDD, NeuroStar TMS is also FDA-cleared in adults for the treatment of both obsessive-compulsive disorder (OCD) and anxious depression.
REMED
REMED, since it’s found in 2003, has been the specialist in Electroceutical area such as Transcranial Magnetic Stimulation (TMS-FDA cleared for the treatment of MDD), Neuro Magnetic Stimulation (NMS), Core Strength Magnetic Stimulation (CSMS). REMED has been supplying and manufacturing medical devices from around the world, and we have been developing together with customers based on the deep trust.
REMED has been, and is trying the best to provide satisfactory results and values to customers. REMED enlarged the clinical applications based on accumulated technology and experience. We reinforced the foreign business such as in US, Europe, Asia and around the world. Our goal is to become the world’s untouchable No.1 global company in the field of Electroceutical with outstanding technology and solutions. REMED pursue the shared value and virtuous cycle of the world.
Rogue Research
Rogue Research has been your partner in neuroscience research for 25 years with Brainsight used in over 1000 labs worldwide and now we offer our integrated Elevate TMS and companion Robot . Elevate Biomedical was recently created to facilitate translation from research to clinical trials to full clinical deployment.
SEBERS Medical
SEBERS Medical makes TMS easy!
SEBERS Medical is a privately owned medical technology company with offices in Germany and the United States. We specialize in developing and marketing cutting-edge TMS solutions for a wide spectrum of applications.
Smart innovations such as the patented TMS Pilot coil positioning and the patented HeadNest™ head positioning system complement our Blossom TMS™ solutions and make TMS easy! SEBERS Medical's solutions are available in more than 30 countries worldwide.
Visit website: https://sebersmedical.com/ 新しいタブ／ウィンドウで開く
SigmaStim
SigmaStim is the world leader in the design, manufacture, and distribution of electroconvulsive therapy (ECT) devices and accessories. The Σigma is the newest ECT device produced by SigmaStim (formerly the MECTA Corporation). This Σigma has the widest range of stimulus parameters and physiological monitoring options of any ECT device. The Σigma is unparalleled in its ease of use, with an intuitive LCD interface allowing instant customization, including selection of single-dial or four-dial modes of operation.
Starting in 1976, with the original MECTA device, SigmaStim introduced the use of constant current, brief pulse ECT, a huge advance over previous constant voltage, sine wave devices. SigmaStim later introduced ultrabrief pulse stimulation and now the Σigma includes an option for ultra-ultrabrief stimulation with pulse widths ranging from 0.15-1.0 ms . SigmaStim introduced multiple other innovations including the continuous assessment of static impedance, true measurement of the delivered electrical stimulus including dynamic impedance, and with the Σigma ECT Device, the measurement of the impedance of each individual physiological recording electrode. The Σigma ECT Device can be coupled with SigmaStim EMR software providing automatic databasing of treatment session parameters, including physiological traces.
SigmaStim is sponsoring a one-day course at this meeting on Feb. 23, 2025, Introduction to Modern ECT Practice. The faculty in this course are Drs. Colleen Loo, W. Vaughn McCall, and Harold A. Sackeim.
Sooma
Founded in 2013, Sooma is a Finnish medical device company specializing in non-invasive brain stimulation devices for neurological and psychiatric disorders. Sooma works closely with leading medical experts to develop effective treatment solutions. Manufactured in Finland, Sooma’s devices adhere to strict ISO 13485 and MDSAP quality management standards. To date, more than 20,000 patients have found relief with these treatments. Sooma Depression Therapy is available in more than 35 countries worldwide.
Soterix Medical
Soterix Medical, the global leader in Noninvasive Neuromodulation, introduced High Definition-transcranial Electrical Stimulation (HD-tES) and remote-supervised tES (RS-tES). HD-tES is the only targeted sub-threshold Neuromodulation technology and allows coupling with research-grade monitoring technologies like EEG, MEG, fNIRS, etc. Coupled with Advanced Neurotargeting software, which allows the design of optimized and individualized stimulation along with the current flow visualization, HD-tES allows customized stimulation for susceptible populations (stroke, pediatric, etc).
RS-tES enables remote delivery of tES maintaining in-clinic compliance and control. Soterix Medical also offers a range of innovative technologies from conventional tDCS, Interferential Stimulation, Transcranial Magnetic Stimulation(TMS), Transcranial Pulse Stimulation, Neuronavigation, HD-ECT, Spinal Cord, Galvanic Vestibular, Vagus Nerve to Animal Stimulation and monitoring solutions (EEG,fNIRS, EMG).
STORZ MEDICAL AG
STORZ MEDICAL AG, founded in 1987, is an independent partner company of the KARL STORZ Group, based in Switzerland.
We develop innovative shock wave systems and discovered the effectiveness of shock waves in treating peripheral neurological diseases in the 1990s. Our focus now includes developing treatments for neurological diseases such as Alzheimer’s, Parkinson’s, stroke and spinal cord injuries.
TMS
An international medical society dedicated to optimizing clinical practice, supporting research, and increasing access to high quality, evidence-based Transcranial Magnetic Stimulation.
Vielight Inc
Vielight Inc. leads in the application of photobiomodulation (PBM) to modulate mental performance. Our proprietary technology, meticulously crafted for convenient home usage, redefines the landscape of brain stimulation.
Our exploration extends to diverse areas like dementia, traumatic brain injury and sports performance, revealing exciting potential. In addition, recent investigations demonstrate that the effect on brain functions are also acute and immediate, as observed with EEG and cognitive performance measures. The ease of use combined with safety suggests that PBM delivered by Vielight is very promising as the next-generation non-invasive brain stimulation method, ideal for lay users, hackers and researchers.
ZMT
ZMT Zurich MedTech AG (ZMT)’s flagship product Sim4Life combines in silico multiphysics and multi-scale computational modelling and simulation with advanced neurofunctionalized high-resolution anatomical models. The aim is to predict and optimize the effectiveness and performance of devices and stimulation parameters.
Together with its strategic partner TI Solutions AG, ZMT will showcase the newly developed Temporal Interference Brain Stimulator for Research (TIBS-R V2.0), the most flexible instrument to advance research on temporal interference stimulation. It’s multi-channel phase modulation capability enables the generation of complex interference waveforms. TIBS-R V2.0 is complemented by a cloud-based planning tool facilitating experimental design and optimization.
Recently, the ZMT team has achieved the impossible, namely releasing the full functionality of the Sim4Life desktop version natively on the web, which allows to access, share and collaborate in real-time.
TIBS-R is complemented by a cloud-based planning tool called TIP, that enables reliable simulations of complex and patient specific set-ups.
YINGCHI
YINGCHI IS AN INNOVATIVE MANUFACTURER FOCUSING ON BRAINSCIENCE EQUIPMENT IN THE FIELDS OF PSYCHOLOGY, NEUROLOGY, COGNITIVE NEUROSCIOLOGY AND REHABILITATION.
YINGCHI develops navigated and automated TMS system including powerful TMS, navigation system and TMS robot as well as solutions for combination of TMS and EEG/EMG. The high-intensity stimulators, efficient air/liquid cooed systems and smart software make the TMS treatment professional and easier. More than 20 coils bring more possibilities for research and medical professionals.
More details please visit www.yingchitech.com 新しいタブ／ウィンドウで開く
Industry sponsored workshops
Magventure | Sunday, 23 February 2025, 9.00 am-12.30 pm Magnetic Seizure Therapy (MST)*: Research Fundamentals and Applications Come listen to some of the top pioneers within the newest research in MST*: Prof. André Brunoni and Prof. Jijun Wang. 3 hours of overviews, newest clinical research results and a panel debate on the future of Convulsion Treatment with Magnetic Seizure Therapy (MST)*. Ask questions and see live the MST* research system – the MagPro XP Black Edition (MST), the most powerful, advanced, and tailored system for the application of MST. *Please note that the MST (Magnetic Seizure Therapy) device showcased during this workshop is intended exclusively for research purposes |
Sigmastim | Sunday, 23 February 2025, 8.00 am-5.00 pm Introduction to Modern ECT Practice SigmaStim is sponsoring the Third International Course on ECT. The course is chaired by Dr. Harold A. Sackeim, Professor, Medical University of South Carolina and Columbia University, USA with Colleen Loo, Professor, Black Dog Institute and University of South Wales, Australia and W. Vaughn McCall, Professor, Augusta University, USA as faculty. The course will review essential knowledge about optimal ECT practice. Topics include: Indications and Patient Selection, Optimizing ECT Technique (anesthesia, ECT administration, concurrent pharmacology, relapse prevention), Physiological Monitoring, Medical and Cognitive Adverse Effects, and Staging and Combining ECT with Ketamine and Other Neuromodulation Interventions. The use of the latest generation ECT device, the SigmaStim ∑igma, will be demonstrated, including electrical stimulus dosing strategies, electrode positioning, and EEG recording. There will be significant time for questions from course participants. Drs. Loo, McCall and Sackeim are highly experienced clinicians and ECT researchers who have made multiple, enduring contributions to ECT practice. Lunch and Coffee/Tea Breaks will be provided, as well as copies of the faculty presentations. View preliminary agenda here [subject to change] 新しいタブ／ウィンドウで開く |
Soterix Medical | Sunday, 23 February 2025, 9:00 am – 5:00 pm Latest Technology Updates in Neuromodulation and Neuromonitoring - Conventional and High Definition transcranial Electrical Stimulation (tES/HD-tES) - Remote Supervised tDCS/tES and HD-tES - Our first hybrid HD-tES and EEG solution (MXN-GO EEG) - Temporal Interference (TI) / Interferential Stimulation (IFS) - Repetitive transcranial Magnetic Stimulation (rTMS) with Soterix Medical SPRY TMS and Neuronavigation. - Transcranial-focused Ultrasound Stimulation (tFUS) - Galvanic Vestibular Stimulation (GVS), transcutaneous Auricular Vagus Nerve Stimulation (taVNS), and closed-loop transcranial Electrical Stimulation (tES) and monitoring. - New and upcoming technologies |
BRAINBOX | Sunday, 23 February 2025, 1:00 pm-5:00 pm Practical Introduction to Transcranial Ultrasound Stimulation Join Brainbox & The Brainbox Initiative for a Sunday afternoon workshop designed to provide attendees with an in-depth understanding of TUS techniques and their applications in non-invasive brain stimulation research. Led by esteemed experts in the field, who will provide attendees with valuable information and insights that they can take back to their own research. Topics covered: - Fundamentals of transcranial ultrasound stimulation (TUS) as a non-invasive brain stimulation techniques - Research applications and uses of TUS - Demonstrations of TUS equipment - Advanced computational modelling techniques for focused ultrasound |
Rogue Research | Monday, 24 February 2025, 7.30 am-8.30 am From target to delivery: Integrated pipeline to facilitate deployment of individualized NIBS Rogue Research specializes in providing tools for non-invasive brain stimulation (NIBS) to researchers, including the Brainsight navigator and Elevate TMS device. We present our next-generation platform for individualized brain stimulation that uses robotics to allow consistent application of targeted TMS or fUS for every subject at every site and supports closed loop research. This integrated approach can yield more consistent multi-center trial data while reducing the technological burden on clinicians delivering treatment. We will present the current state of our integrated vision including all the steps from target selection to placement optimization using modeling to stimulation delivery using our Brainsight-controlled robot. We also present our collaborative platform to remotely manage centralization of the treatment planning process and prescription delivery to clinical sites for automated application. Register for the event here 新しいタブ／ウィンドウで開く. |
STORZ MEDICAL AG | Tuesday, 25 February 2025, 7.30 am-8.30 am Transcranial Pulse Stimulation (TPS): New horizons in non-invasive brain stimulation Transcranial Pulse Stimulation (TPS) is an innovative treatment for patients with Alzheimer’s dementia, utilizing low-energy acoustic pulse waves to target affected brain regions. [more information here 新しいタブ／ウィンドウで開く]. |
Vielight | Tuesday, 25 February 2025, 7.30 am-8.30 am The Continuing Rise of Photobiomodulation in Brain Stimulation - Updates for 2025 Join us for an exclusive presentation on the latest advancements in Photobiomodulation (PBM) technology and its growing influence in the field of brain stimulation. As research continues to unfold, PBM is emerging as a powerful, non-invasive tool for enhancing cognitive function, improving mental health, and treating neurological conditions. In this session, we will provide updates for 2025, including cutting-edge research, clinical outcomes, and novel applications of PBM in both therapeutic and performance-enhancement contexts. Attendees will gain insight into where PBM stands in comparison to other brain stimulation modalities, and why it is becoming a compelling option in brain health strategies. Key topics to be covered: - New clinical evidence and breakthrough studies - Newly discovered mechanisms of action, including findings at the cellular level - Integration of PBM with TMS and tDCS - Future directions and potential applications for PBM This presentation is designed for neuroscientists, clinicians, and innovators in brain health who are looking to stay at the forefront of non-invasive brain stimulation technologies. Don’t miss the opportunity to explore the continuing rise of PBM and how it’s shaping the future of brain stimulation. The presentation will be made by Dr. Lew Lim of Vielight Inc., one of the foremost knowledge leaders in the brain PBM field. |
ZMT Swiss | Tuesday, 25 February 2025, 7.30 am-8.30 am From Exposure Physics to Physiology: Next-Generation Neuromodulation Research with Sim4Life Join us to explore how ZMT Zurich MedTech AG’s computational platform, Sim4Life, can streamline and accelerate cutting-edge neuromodulation research. This workshop will showcase comprehensive modeling and simulation techniques that integrate exposure physics with the physiology of neural responses. Attendees will gain firsthand insight into the creation of automated workflows that effectively address complex challenges in neuromodulation research, empowering them to amplify the impact of their work in this rapidly evolving field. Drawing on real-world examples, we will cover critical applications, emphasizing practical implementations and outcomes. Workshop Highlights: - Introduction to the use of Sim4Life for neuromodulation applications and in silico modeling - Case studies: Safety assessments for patients with neural implants Hippocampal TIS: optimization of targeting and analysis of subject-specific responses Personalized modeling of brain responses to non-invasive stimulation - Latest advances in Sim4Life: tissue segmentation and predictions of neural activations The workshop is designed for researchers and clinicians looking to enhance their understanding of computational modeling in neuromodulation, with a particular emphasis on personalized approaches, safety assessments, and the development of novel stimulation paradigms. Join us for a morning of energizing discussion and continued learning! Duration: 60 minutes Format: Interactive presentation with Q&A Target Audience: Neuromodulation researchers, computational neuroscientists, clinical scientists REGISTER HERE 新しいタブ／ウィンドウで開く |
BRAINBOX | Wednesday, 26 February 2025, 7.30 am-8.30 am Latest Advancements in TMS-EEG Join the Brainbox Initiative for an engaging breakfast workshop at Brain Stimulation 2025, where we’ll explore the latest advancements in TMS-EEG. This session will provide insights into cutting-edge methodologies, integration techniques, and how these developments are transforming brain stimulation research. |
Reasons why being a sponsor is a brilliant marketing strategy
Highly targeted marketing – reach your community
Brand awareness & recognition – logo and advertisement placement
Access to knowledge – find out about new research being undertaken
Engage with your audience – at the event and online
Media exposure - benefit from being promoted throughout Elsevier’s marketing process
Enhance credibility – highlight your company’s expertise to a captive audience
Generate new sales & form new partnerships – with registrants, vendors and speakers
Leveraged lead generation - the chance to be recommended to attendees’ connections
An exhibition will run alongside the conference sessions. Space is available on a first-come, first-served basis. In addition, a range of commercial sponsorship opportunities are available.
To discuss your requirements or to book sponsorship or exhibit space please contact:
Chloe Partridge Sales Manager, Conferences STM Journals | Elsevier Mob: +44 (0)7771 840678 Office: +44 (0)1865 843346 Email: [email protected] 新しいタブ／ウィンドウで開く
2023 Sponsors and Exhibitors
We would like to thank our 2023 sponsors and exhibitors:
5th International Brain Stimulation Conference 19–22 February 2023 | Lisbon, Portugal
Sponsors/Exhibitors
Gold Sponsor Brainbox LivaNova
Silver Sponsors ASMED Srl MagVenture TMS Research ® MECTA/SigmaStim STORZ MEDICAL
Sponsors Magstim Neurophet NeuroStar Nexstim Rogue Research Vielight
Exhibitors ANT Neuro ASMED Srl Axilum Robotics BrainBox BrainsWay Bittium CED Clinical TMS Society Deymed Electromedical Products International g.tec Ionclinics LivaNova Localite Mag & more neurocare group AG Magstim EGI MagVenture TMS Research® MECTA/SigmaStim Machine Medicine Neurocare Neuroelectrics Barcelona, SLU Neuronic Neuronjourney Neurophet Nexstim Nova Bioelectrics REMED Rogue Research Sooma Soterix Medical STORZ MEDICAL Vielight ZMT
Other workshops
Brain Stimulation at the Microscopic Scale: Multiscale Models and Cellular Studies Sunday, 23 February 2025, 9.00 am-5.00 pm
The workshop will cover the most recent experimental and modeling results on the cellular mechanisms of brain stimulation mechanisms. The workshop focuses on the latest concept and recording/analysis tools characterizing cell and network response to brain stimulation, and new computational modeling techniques. Concepts are relevant to all forms of non-invasive (e.g., TES, tDCS, tACS, TMS) and in invasive (e.g., direct electrical stimulation, DBS, invasive magnetic stimulation) electrical stimulation. Translational aspects including dose optimization based on individual imaging and recording, pulse shape optimization, plasticity induction, and novel cellular targets such as vascular stimulation. The workshop will also address advanced brain ultra-structure and imaging techniques as they provided new data for understanding brain stimulation mechanisms and modeling.